Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study

Study limitation reported by the research below: “Group G's apparently elevated ratio (1.84) is attributed to baseline instability rather than a true increase in risk, which may be misread without context.”